The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
tecovirimat monohydrate · TECOVIRIMAT MONOHYDRATE 200 mg/1 · Capsule · Oral · SIGA Technologies, Inc.
NDC 50072-0200-42 · 42 CAPSULE in 1 BOTTLE · NDA · View full market →
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
| Type | Number / code | Expires |
|---|---|---|
| patent | 11890270 | Aug 8, 2032 |
| patent | 7737168 | Sep 4, 2031 |
| patent | 9339466 | Mar 23, 2031 |
| patent | 12433868 | Mar 23, 2031 |
| patent | 8039504 | Jul 23, 2027 |
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| SIGA Technologies, Inc. | TECOVIRIMAT MONOHYDRATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Tpoxx — NDC 50072-0200-42," retrieved September 3, 2026, https://drugdashboards.com/drug/50072020042.
Free to cite with attribution — see how the data is put together.